Have you perfected the work/life balance?
December 3, 2004Perfecting the balance between work and the rest of life is increasingly a concern for employees and employers – based …
Life-saving licence to boost Diovan
December 2, 2004Sales of Novartis' hypertension treatment Diovan look set to increase following the granting of a new European Union licence for …
Cegedim service provides ‘integrated picture’ of markets
December 1, 2004Pharmaceutical marketing data specialist Cegedim has launched a suite of new services to help pharma companies better understand their customers …
Breakthrough MS drug tipped for blockbuster status
November 30, 2004The US has approved Tysabri, an innovative new drug which could offer new hope for sufferers of multiple sclerosis and …
Independent agencies band together in global network
November 26, 2004PAN Advertising has formed a global network of independent healthcare communications agencies they hope will allow them to challenge the …
AstraZeneca and CAT in long-term research partnership
November 24, 2004AstraZeneca has announced a five-year research and development alliance with Cambridge Antibody Technology for the joint discovery of antibody drugs, …
Leading by example
November 24, 2004Selling medicines has always been a complicated business. The end user of the new product is ultimately the patient, but …
Spearhead PCTs to tackle health inequality
November 23, 2004PCTs in some of England's most deprived areas are to lead a new drive to tackle public health problems such …
Strict new conflict of interest rules for MHRA proposed
November 19, 2004Growing concerns about the independence and transparency of the UK medicines regulator have been met by a set of strict …
Raptiva launched in first European markets
November 18, 2004Serono's new psoriasis treatment Raptiva has been launched in its first European markets, including the UK.The drug is licensed to …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
